Title : Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma.

Pub. Date : 2019 Mar

PMID : 30581162






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Addition of rituximab to a reduced dose (RD) of cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy might improve patient outcomes with an improved toxicity profile when provided to elderly patients with diffuse large B-cell lymphoma. Prednisolone DNA damage inducible transcript 3 Homo sapiens